|
|||||
|
|
| 清心饮Ⅱ号对病毒性心肌炎小鼠药效学的研究 | |
| 引用本文： | 程志清, 熊福林. 清心饮Ⅱ号对病毒性心肌炎小鼠药效学的研究[J]. 中国现代应用药学, 2003, (3): 191-194. |
| 作者姓名： | 程志清 熊福林 |
| 作者单位： | 浙江中医学院,浙江,杭州,310053 |
| 基金项目： | 浙江省自然基金 3 0 0 42 5，浙江省科技厅资助项目 99110 3 175 |
| 摘 要： | 目的 通过前期拆方研究后而组成的清心饮Ⅱ号进行不同剂量的药效学与作用机制研究，明确该方在实验动物中的有效治疗剂量，为新药开发提供实验依据。方法 通过检到用药10d后小鼠体重变化、血清中肌钙蛋白Ⅰ(cTnⅠ)、SOD及MDA的变化、小鼠心肌中病毒滴度水平，验证该方的疗效。结果 清心饮Ⅱ号高剂量组和中剂量组均能有效降低小鼠心肌中病毒滴度和减轻心肌中的病理改变；清心饮Ⅱ号中剂量组能显著降低小鼠血清中cTnⅠ的含量，清心饮Ⅱ号高、中剂量组均能有效提高血清中SOD含量和降低血清中MDA的水平。结论 清心饮Ⅱ号对VMC小鼠有显著疗效。 |
| 关 键 词： | 方剂/清心饮Ⅱ号 病毒性心肌炎 药效学 |
| 文章编号： | 1007-7693(2003)03-0191-04 |
Pharmacodynamic study of Qingxinyin II on viral myocarditis in mice model |
|
| CHENG Zhi-qing, XIONG Fu-lin. Pharmacodynamic study of Qingxinyin II on viral myocarditis in mice model[J]. Chinese Journal of Modern Applied Pharmacy, 2003, (3): 191-194. | |
| Authors: | CHENG Zhi-qing XIONG Fu-lin |
| Abstract: | OBJECTIVE By pharmacodynamics study on different dose of Qingxinyin II(QXY II), which was developed based on the previous variation study of recipe components, the effective dose of QXY II for experimental animal was verified to support the future new medicine development. METHOD Treatment effectiveness of QXY II was demonstrated by measuring the virus titers level in mice myocarditis and changes in mice body weight, the serum cardiac troponin I (cTnI), superoxide Dismutase (SOD) and malon dialdehyde (MDA) after 10 days treatment. RESULTS High dose and middle dose group both can effectively decrease the virus titers and the pathological changes in mice myocarditis, raise the SOD level in serum while lower the level of MDA. Middle dose group can significantly lower the level of cTnI in serum. CONCLUSION Significant treatment effectiveness of QXY II was found, especially for high dose and middle dose group. |
| Keywords: | China Herbs Decoction / Qinxinying II viral myocarditis pharmacodynamics |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ | |
| 点击此处可从《中国现代应用药学》浏览原始摘要信息 | |
| 点击此处可从《中国现代应用药学》下载全文 | |